Nonetheless, experiments with mouse models, and analysis of human cancer samples treated with the above agents, need to be performed to validate our observation that DNA‐damaging agents and CDK4/6i‐induced senescence could have the potential to regulate the TME in different ways. Here, CDK4 is linked to cancer.